Regulatory Watch
June 2025: FDA raids Amino Asylum warehouse; website goes offline, operations cease Feb 2025: FDA declares semaglutide shortage resolved — compounding exception ends Sept 2025: FDA issues 50+ warning letters to GLP-1 compounders; DOJ involvement confirmed Nov 2025: Alabama obtains TRO against GLP-1 distributors — first state-level injunctive relief Sept 2023: FDA moves BPC-157, TB-500, and 15 other peptides to Category 2 — compounding prohibited Dec 2024: PCAC votes against allowing compounding of ipamorelin, MK-677, CJC-1295, AOD-9604 Jan 2025: FDA eliminates Category 2/3 system; prohibited substances remain prohibited Feb 2026: STAT News: 35 of 36 BPC-157 studies are animal-only from single lab with undisclosed conflicts 2025: Chinese peptide imports to US double to $328M; online peptide advertising up 678% since 2022 June 2025: FDA raids Amino Asylum warehouse; website goes offline, operations cease Feb 2025: FDA declares semaglutide shortage resolved — compounding exception ends Sept 2025: FDA issues 50+ warning letters to GLP-1 compounders; DOJ involvement confirmed Nov 2025: Alabama obtains TRO against GLP-1 distributors — first state-level injunctive relief Sept 2023: FDA moves BPC-157, TB-500, and 15 other peptides to Category 2 — compounding prohibited Dec 2024: PCAC votes against allowing compounding of ipamorelin, MK-677, CJC-1295, AOD-9604 Jan 2025: FDA eliminates Category 2/3 system; prohibited substances remain prohibited Feb 2026: STAT News: 35 of 36 BPC-157 studies are animal-only from single lab with undisclosed conflicts 2025: Chinese peptide imports to US double to $328M; online peptide advertising up 678% since 2022

How We Rate Vendors

Transparency COA availability, company info, manufacturing details
Testing Third-party verification, testing frequency, lab accreditation
Pricing Value relative to quality, price transparency, no bait-and-switch
Compliance FDA warning letters, legal claims, regulatory history
Full methodology →

These vendors meet our standards for transparency and testing. We have varying degrees of confidence in each, reflected in their individual grades.

Vendor Grade Transparency Testing Pricing Compliance COA 3rd Party
Science.bio (Closed) A- 95 90 70 40 View →
Peptide Partners B+ 80 90 55 65 View →
Eternal Peptides B 70 80 55 60 View →
Verified Peptides B 75 75 55 60 View →

Acceptable with Reservations

B- to C

These vendors have some transparency or testing gaps. Usable, but verify individual product COAs and research recent community feedback.

Vendor Grade Transparency Testing Pricing Compliance COA 3rd Party
Peptide Sciences B- 50 65 55 50 View →
ProHealth Longevity B- 70 65 60 80 View →
Trident Peptides B- 55 50 60 55 View →
Infiniwell C+ 45 50 30 50 View →
Integrative Peptides C+ 40 55 35 45 View →
Paradigm Peptides C+ 45 60 50 55 View →
Swisschems C+ 50 55 75 40 View →
Core Peptides C 50 45 55 50 View →
Limitless Life Nootropics C 45 50 55 45 View →

Use with Caution

C- or Lower

Significant concerns about transparency, testing, or compliance. Consider alternatives unless you have specific reasons to proceed.

Vendor Grade Transparency Testing Pricing Compliance COA 3rd Party
Prime Peptides C- 50 55 55 25 View →
Strate Labs C- 50 60 70 20 View →
LVLUP Health D+ 40 45 50 35 View →